Results 291 to 300 of about 134,089 (350)

Coevolution of Human Diet and Gut Microbiome: Implications for Nutrigenomics and Cross-Population Health. [PDF]

Int J Microbiol
Sandra F, Scania AE, Dewi NM, Ranggaini D, Halim J, Pakpahan A, Lee KH.   +6 more
europepmc   +1 more source

The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 2, Page 208-221, July 2026.
In a cohort of IBS‐D patients recruited to the TRITON study, faecal metabolomic profiling reveals a SCFA‐enriched metabotype associated with increased pain and urgency, altered stool characteristics and accelerated intestinal transit. ABSTRACT Background Metabolomic analysis in irritable bowel syndrome (IBS) has identified metabotypes enriched in ...
T. E. Conley, A. Duncan, A. Modasia, A. C. Ford, D. M. Pritchard, F. Hildebrand, F. J. Warren, R. Spiller, C. S. Probert   +8 more
wiley   +1 more source

Revisiting Hyaluronan Catabolism in Bacteroides: Pathway Conservation, Overlooked Proteins, and Predictive Accuracy. [PDF]

Microbiologyopen
Sindelar M, Kocurkova A, Simek M, Roudnicky P, Ambrozova G, Kubala L, Turkova K.   +6 more
europepmc   +1 more source

Bifidobacterium bifidum G9‐1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open‐Label, Randomized Controlled Trial (Binary STAR Study)

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5952-5967, July 2026.
ABSTRACT Aims To evaluate the effects of probiotics Bifidobacterium bifidum G9‐1 (BBG9‐1) on gastrointestinal symptoms in patients with Type 2 diabetes mellitus (T2DM) with diarrhoea or constipation. Materials and Methods In a 12‐week open‐label randomised controlled trial, 100 participants were randomized 1:1 to a control or BBG9‐1 group, with 12 mg ...
Genki Kobayashi, Yoshitaka Hashimoto, Tomoyuki Matsuyama, Noriyuki Kitagawa, Saori Majima, Takafumi Senmaru, Emi Ushigome, Hiroshi Okada, Naoko Nakanishi, Masahide Hamaguchi, Michiaki Fukui   +10 more
wiley   +1 more source

Microbiomics: Novel Biomarkers of Colorectal Cancer Diagnosis and Prognosis. [PDF]

Diagnostics (Basel)
Yang L, Meng W, Yang T, Zhu Y, Wang Z.
europepmc   +1 more source

Periodontitis and Periodontal Conditions in Systemically Healthy Children and Adolescents

Journal of Clinical Periodontology, Volume 53, Issue 7, Page 1100-1198, July 2026.
ABSTRACT Objective To answer the PICoS question ‘in systemically healthy children and adolescents (Population), what are the main features of periodontitis, necrotising periodontal diseases (NPD) and other periodontal conditions (periodontal abscesses, endo‐periodontal lesions, traumatic occlusal forces, prosthesis‐ and tooth‐related factors ...
Inbar Eshkol‐Yogev, Nagore Ambrosio, Cheryl Somani, Elena Figuero, Lior Shapira, Janet Davies   +5 more
wiley   +1 more source

Distinct prophage infections in colorectal cancer-associated Bacteroides fragilis. [PDF]

Commun Med (Lond)
Damgaard F, Jespersen MG, Møller JK, Coia JE, Dessau RB, Sydenham TV, Strube ML, Møller-Jensen J, Justesen US.   +8 more
europepmc   +1 more source

The Gut Microbiome in Early Ontogeny: Implications for Brain and Immune System Development. [PDF]

J Dev Biol
Borrego-Ruiz A, Borrego JJ.
europepmc   +1 more source

Anaerobes in Late-Onset Prosthetic Joint Infection (PJI) and Colorectal Carcinoma. [PDF]

J Clin Med
Chiu ST, Tan MH, Goh SK, Han AX, Pang HN, Yeo SJ, Xu S, Liu Xuan E.   +7 more
europepmc   +1 more source